Korean Drug Revenue

In the year 2025, Korean Drug had annual revenue of 62.51B KRW, down -14.37%. Korean Drug had revenue of 18.00B in the quarter ending December 31, 2025, with 1.67% growth.

Revenue

62.51B

Revenue Growth

-14.37%

P/S Ratio

0.74

Revenue / Employee

231.51M

Employees

270

Market Cap

46.16B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.51B	-10.49B	-14.37%
Dec 31, 2024	73.00B	-8.37B	-10.29%
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HLscience	16.71B
GeneBioTech Co. ,Ltd	90.79B
Eagle Veterinary Technology Co.,Ltd	43.32B
RP Bio	136.22B
Korea Arlico Pharm	201.20B
Kyung Nam Pharm	56.18B
Seoul Pharma	52.15B
Jin Yang Pharmaceutical	120.69B

Revenue Rankings